These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10523137)

  • 21. Serum drug level-related sodium valproate-induced hair loss.
    Ramakrishnappa SK; Belhekar MN
    Indian J Pharmacol; 2013; 45(2):187-8. PubMed ID: 23716898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of the immunosuppressive effect of some anticonvulsants in children].
    Massimo L; Pasino M; Rosanda Vadalá C; Tonini GP; Perutelli P; Saccomani L
    Minerva Pediatr; 1977 Apr; 29(12):837-41. PubMed ID: 327255
    [No Abstract]   [Full Text] [Related]  

  • 23. A case with Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine, and valproic acid treatment.
    Ertam I; Sezgin AO; Unal I
    Int J Dermatol; 2009 Jan; 48(1):98-9. PubMed ID: 19126064
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuroblastoma, maternal valproic acid use, in-vitro fertilization and family history of mosaic chromosome 22: coincidence or causal relationship?
    Merks JH; Ceelie N; Caron HN; Hennekam RC
    Clin Dysmorphol; 2004 Jul; 13(3):197-198. PubMed ID: 15194961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium valproate -- induced skeletal myopathy.
    Kasturi L; Sawant SP
    Indian J Pediatr; 2005 Mar; 72(3):243-4. PubMed ID: 15812121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproate-associated stomatitis.
    Ryan M; Baumann RJ; Miller CS; Baker C
    J Child Neurol; 2002 Mar; 17(3):225-7. PubMed ID: 12026241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
    Fernández Colomer B; Rekarte García S; García López JE; Pérez González C; Montes Granda M; Coto Cotallo GD
    An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fatal hepatic necrosis during treatment with sodium valproate].
    Miguil M; Chlihi A; Mjahed K; Sarf I; Moutawakkil S; Benaguida M
    Cah Anesthesiol; 1995; 43(3):325-6. PubMed ID: 7583902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible carbamazepine-induced reversible onychomadesis.
    Mishra D; Singh G; Pandey SS
    Int J Dermatol; 1989 Sep; 28(7):460-1. PubMed ID: 2777446
    [No Abstract]   [Full Text] [Related]  

  • 30. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
    Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
    Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
    [No Abstract]   [Full Text] [Related]  

  • 32. Valproic acid therapy inducing absence status evolving into generalized seizures.
    Shahar E; Andraus J; Sagie-Lerman T; Savitzki D
    Pediatr Neurol; 2002 May; 26(5):402-4. PubMed ID: 12057805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of epileptic seizures resistant to phenobarbital in children during the first year of life].
    Rudenko AIu; Konoplianko TV; Stetsiuk RA
    Lik Sprava; 2002; (1):52-6. PubMed ID: 11944381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke.
    Gruppo R; Degrauw A; Fogelson H; Glauser T; Balasa V; Gartside P
    J Pediatr; 2000 Nov; 137(5):714-8. PubMed ID: 11060540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation between renal tubular dysfunction and serum carnitine deficiency in cases with valproate therapy].
    Ono H
    No To Hattatsu; 2009 Sep; 41(5):363-5. PubMed ID: 19764458
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acute Intermittent porphyria and valproic acid].
    Noval Menéndez J; Campoamor MT; Laborda B; López-Colina G
    Rev Clin Esp; 2012 Apr; 212(4):217-8. PubMed ID: 22112281
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypoalbuminemia with valproic acid administration.
    Rugino TA; Janvier YM; Baunach JM; Bilat CA
    Pediatr Neurol; 2003 Nov; 29(5):440-4. PubMed ID: 14684241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyponatremia due to sodium valproate.
    Branten AJ; Wetzels JF; Weber AM; Koene RA
    Ann Neurol; 1998 Feb; 43(2):265-7. PubMed ID: 9485070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valproate-induced hyperammonemia and seizures: perioperative concerns.
    Garg R; Sunder RA
    Paediatr Anaesth; 2011 Oct; 21(10):1084-5. PubMed ID: 21981101
    [No Abstract]   [Full Text] [Related]  

  • 40. Reversible valproate-induced choreiform movements.
    Gunal DI; Guleryuz M; Bingol CA
    Seizure; 2002 Apr; 11(3):205-6. PubMed ID: 12018966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.